Genmab | GEN - Ingresos Por Ventas

Precio De Mercado
1,649.00
Cambio Diario
-6.50 -0.39%
Mensual
-10.04%
Anual
24.74%
Q1 Expectativa
1,553.02




Ventas Cambio Fecha
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Almirall EUR 547.63M 12.83M 2025-12
Amarin USD 49.22M 451K 2025-12
Amgen USD 9.9B 340M 2025-12
argenx SE USD 1.12B 132.91M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Demant DKK 6.26B 810M 2025-12
Exelixis USD 598.66M 860K 2025-12
Fresenius Medical Care EUR 5.07B 180M 2025-12
Galapagos EUR 900.82M 835.52M 2025-12
Genmab DKK 1.06B 36M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
GN Store Nord DKK 4.68B 720M 2025-12
GRIFOLS EUR 1.98B 110M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.25B 70M 2025-12
Novartis USD 13.86B 50M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
UCB EUR 4.25B 764M 2025-12